MeiraGTx gene therapy (unspecified product)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MeiraGTx gene therapy (unspecified product), covering 2021-04-08 to 2021-04-08. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial of Gene Therapy for the Treatment of Leber Congenital Amaurosis (LCA) [Phase 1, Phase 2]